In line with our mouse tumor results, patient BRCA1-mutant breast tumors have significantly higher enrichment scores of M2 macrophage gene signature30,31 than BRCA1-mutant ovarian tumors (Supplementary Fig. 1l, m). The gene discussed is BRCA1; the disease is ovarian neoplasm.